CBP Ruling Database
Search past U.S. Customs and Border Protection classification rulings. Find precedent for your product and cite it in your own classification.
1142 rulings found
The tariff classification and country of origin marking of ampoules containing Apomorphine Hydrochloride as the active ingredient; ARTICLE 509
The tariff classification and country of origin marking of ampoules containing Apomorphine Hydrochloride as the active ingredient; ARTICLE 509
Reconsideration of NY I84690; PrismaSate BK0/3 and PrismaSate BK2/0 dialysate solutions
Reconsideration of NY I84690; PrismaSate BK0/3 and PrismaSate BK2/0 dialysate solutions
The tariff classification of Tipranavir® Capsules from Germany
The tariff classification of Tipranavir® Capsules from Germany
The tariff classification of Styptic Powder from China and Taiwan
The tariff classification of Styptic Powder from China and Taiwan
The tariff classification of Doan’s Caplets from Canada
The tariff classification of Doan’s Caplets from Canada
The tariff classification of RESTASIS™ (cyclosporine ophthalmic emulsion) 0.05%, imported put up in single-use vials, from Ireland
The tariff classification of RESTASIS™ (cyclosporine ophthalmic emulsion) 0.05%, imported put up in single-use vials, from Ireland
The tariff classification of Amevive® (alefacept), Alefacept (CAS-222535-22-0), imported in bulk form and single-dose vials, from Germany
The tariff classification of Amevive® (alefacept), Alefacept (CAS-222535-22-0), imported in bulk form and single-dose vials, from Germany
The tariff classification of Triple antibiotic ointment (Item No. 0050), Antibiotic plus pain cream (Item No. 0051), Diaper Rash Ointment (Item No. 0052), Hydrocortisone 1% cream (Item No. 0055) and Tolnaftate Antifungal cream (Item No. 0058) over-the-counter medicaments, from Korea
The tariff classification of Triple antibiotic ointment (Item No. 0050), Antibiotic plus pain cream (Item No. 0051), Diaper Rash Ointment (Item No. 0052), Hydrocortisone 1% cream (Item No. 0055) and Tolnaftate Antifungal cream (Item No. 0058) over-the-counter medicaments, from Korea
The tariff classification of Triple antibiotic ointment (Item No. 0050), Antibiotic plus pain cream (Item No. 0051), Diaper Rash Ointment (Item No. 0052), Hydrocortisone 1% cream (Item No. 0055) and Tolnaftate Antifungal cream (Item No. 0058) over-the-counter medicaments, from Korea
The tariff classification of Triple antibiotic ointment (Item No. 0050), Antibiotic plus pain cream (Item No. 0051), Diaper Rash Ointment (Item No. 0052), Hydrocortisone 1% cream (Item No. 0055) and Tolnaftate Antifungal cream (Item No. 0058) over-the-counter medicaments, from Korea
The tariff classification of FLUOROPLEX® (fluorouracil) 1% Topical Cream and FLUOROPLEX® (fluorouracil) 1% Topical Solution, supplied put up in 30 g tubes and 30 ml plastic bottles with droppers, respectively, from Canada
The tariff classification of FLUOROPLEX® (fluorouracil) 1% Topical Cream and FLUOROPLEX® (fluorouracil) 1% Topical Solution, supplied put up in 30 g tubes and 30 ml plastic bottles with droppers, respectively, from Canada
The tariff classification of MLN1021, imported in bulk and measured-dose forms, for use in Phase 1 clinical trials, from the United Kingdom and Canada
The tariff classification of MLN1021, imported in bulk and measured-dose forms, for use in Phase 1 clinical trials, from the United Kingdom and Canada
The tariff classification of liquid-filled glass vials ("cartridges") containing the investigational drug Exenatide (CAS-141732-76-5) as the active ingredient, and the tariff classification of a disposable pen injector fitted with a non-removable, liquid-filled glass vial ("cartridge") containing the investigational new drug Exenatide as the active ingredient, both from the United Kingdom
The tariff classification of liquid-filled glass vials ("cartridges") containing the investigational drug Exenatide (CAS-141732-76-5) as the active ingredient, and the tariff classification of a disposable pen injector fitted with a non-removable, liquid-filled glass vial ("cartridge") containing the investigational new drug Exenatide as the active ingredient, both from the United Kingdom
The tariff classification of IDD-D™ Propofol Injectable Emulsion 2%, imported put up in vials for use in Phase III clinical trials, from Sweden
The tariff classification of IDD-D™ Propofol Injectable Emulsion 2%, imported put up in vials for use in Phase III clinical trials, from Sweden
The tariff classification of Anti-Itch Cream (Item No. 0053), Acne Treatment Cream (Item No. 0054), Hemorrhoidal Ointment (Item No. 0056), Oral Pain Relief Ointment (Item No. 0057) and Muscle & Joint Pain Relief Gel (Item No. 0059) over-the-counter medicaments, from Korea
The tariff classification of Anti-Itch Cream (Item No. 0053), Acne Treatment Cream (Item No. 0054), Hemorrhoidal Ointment (Item No. 0056), Oral Pain Relief Ointment (Item No. 0057) and Muscle & Joint Pain Relief Gel (Item No. 0059) over-the-counter medicaments, from Korea
The tariff classification of Anti-Itch Cream (Item No. 0053), Acne Treatment Cream (Item No. 0054), Hemorrhoidal Ointment (Item No. 0056), Oral Pain Relief Ointment (Item No. 0057) and Muscle & Joint Pain Relief Gel (Item No. 0059) over-the-counter medicaments, from Korea
The tariff classification of Anti-Itch Cream (Item No. 0053), Acne Treatment Cream (Item No. 0054), Hemorrhoidal Ointment (Item No. 0056), Oral Pain Relief Ointment (Item No. 0057) and Muscle & Joint Pain Relief Gel (Item No. 0059) over-the-counter medicaments, from Korea
The tariff classification of MLN608, imported in bulk and measured-dose forms, for use in Phase 1 clinical trials, from the United Kingdom and Canada
The tariff classification of MLN608, imported in bulk and measured-dose forms, for use in Phase 1 clinical trials, from the United Kingdom and Canada
The tariff classification of ZYMAR™ (gatifloxacin ophthalmic solution) 0.3%
The tariff classification of ZYMAR™ (gatifloxacin ophthalmic solution) 0.3%
The tariff classification of MLN518, imported in bulk and measured-dose forms, for use in Phase 1 clinical trials, from the United Kingdom and Canada
The tariff classification of MLN518, imported in bulk and measured-dose forms, for use in Phase 1 clinical trials, from the United Kingdom and Canada
The tariff classification of Genasense™ (oblimersen sodium), imported put up in single-use 10 mL glass vials for IV infusion, from Germany
The tariff classification of Genasense™ (oblimersen sodium), imported put up in single-use 10 mL glass vials for IV infusion, from Germany
The tariff classification of FLOXIN® Otic (ofloxacin otic solution) 0.3%, imported put up in plastic multiple-dose bottles, from Finland
The tariff classification of FLOXIN® Otic (ofloxacin otic solution) 0.3%, imported put up in plastic multiple-dose bottles, from Finland
The tariff classification of Activase® (Alteplase recombinant), Avastatin™ (bevacizumab), Cathflo™Activase® (Alteplase) and Herceptin® (Trastuzumab)
The tariff classification of Activase® (Alteplase recombinant), Avastatin™ (bevacizumab), Cathflo™Activase® (Alteplase) and Herceptin® (Trastuzumab)
The tariff classification of Activase® (Alteplase recombinant), Avastatin™ (bevacizumab), Cathflo™Activase® (Alteplase) and Herceptin® (Trastuzumab)
The tariff classification of Activase® (Alteplase recombinant), Avastatin™ (bevacizumab), Cathflo™Activase® (Alteplase) and Herceptin® (Trastuzumab)
The tariff classification of Pulmozyme® (dornase alfa) Inhalation Solution; Raptiva® (Efalizumab) for injection, subcutaneous; Rituxan® (Rituximab); TNKase™ (Tenecteplase); and Xolair® (Omalizumab) for subcutaneous use
The tariff classification of Pulmozyme® (dornase alfa) Inhalation Solution; Raptiva® (Efalizumab) for injection, subcutaneous; Rituxan® (Rituximab); TNKase™ (Tenecteplase); and Xolair® (Omalizumab) for subcutaneous use
The tariff classification of Pulmozyme® (dornase alfa) Inhalation Solution; Raptiva® (Efalizumab) for injection, subcutaneous; Rituxan® (Rituximab); TNKase™ (Tenecteplase); and Xolair® (Omalizumab) for subcutaneous use
The tariff classification of Pulmozyme® (dornase alfa) Inhalation Solution; Raptiva® (Efalizumab) for injection, subcutaneous; Rituxan® (Rituximab); TNKase™ (Tenecteplase); and Xolair® (Omalizumab) for subcutaneous use
The tariff classification of Pulmozyme® (dornase alfa) Inhalation Solution; Raptiva® (Efalizumab) for injection, subcutaneous; Rituxan® (Rituximab); TNKase™ (Tenecteplase); and Xolair® (Omalizumab) for subcutaneous use
The tariff classification of Pulmozyme® (dornase alfa) Inhalation Solution; Raptiva® (Efalizumab) for injection, subcutaneous; Rituxan® (Rituximab); TNKase™ (Tenecteplase); and Xolair® (Omalizumab) for subcutaneous use